Align Technology's Q1 Revenue, Profit Beat Estimates; FY Guidance Maintained
ALGN sits 54% above its 52-week low of $122.
Summary
Align Technology reported strong first-quarter results, with revenue reaching $1.04 billion and adjusted EPS of $2.58, both surpassing analyst consensus estimates of $1.02 billion and $2.28, respectively. This positive performance was driven by higher clear aligner shipments, particularly with double-digit growth in EMEA, APAC, and LATAM. The company also reaffirmed its full-year 2026 revenue growth guidance of 3% to 4% year-over-year, signaling confidence in its outlook despite anticipating some impact from the Middle East conflict on Q2 demand. Additionally, Align completed a $200 million share repurchase program during the quarter. This solid earnings beat and maintained guidance are significant positive catalysts for the stock, indicating robust operational health and stable market demand.
At the time of this announcement, ALGN was trading at $187.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.8B. The 52-week trading range was $122.00 to $208.31. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.